“…The FHI adopted American chestnut as its “test case” (FHI, 2018) and, in the interest of making rapid progress in the development and field testing of disease-resistant American chestnut trees, enrolled experts already working on American chestnut, including the team at SUNY-ESF and researchers affiliated with TACF. FHI projects have now ended, but they funded a number of developments that have dramatically increased the integration of genetic technologies into chestnut restoration, including assays for earlier detection of blight resistance in transgenic plants (Newhouse et al., 2014), improved somatic embryogenesis techniques for generating whole plants from transformed cells (Holtz et al., 2016), a reference genome for Chinese chestnut (Fang et al., 2013; Kubisiak et al., 2013), and the transformation of American chestnut embryos with candidate blight resistance genes from Chinese chestnut (FHI, 2018). FHI aimed to be ground-breaking in both its commitment to public interests and its “braided process” that considered regulatory, environmental, and social dimensions of the use of genetic technologies for forest health, concurrent with the development of scientific knowledge and protocols (FHI, 2018).…”